|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.43 INR | +0.59% |
|
-.--% | -21.15% |
| 2022 | R J Biotech Limited Auditor Raises 'Going Concern' Doubt | CI |
| 2022 | R J Biotech Limited Reports Earnings Results for the Full Year Ended March 31, 2022 | CI |
R J Biotech Limited reported earnings results for the half year ended September 30, 2021. For the half year, the company reported sales was INR 116.74 million compared to INR 135.35 million a year ago. Revenue was INR 119.44 million compared to INR 135.35 million a year ago.
Net loss was INR 0.381 million compared to INR 151.59 million a year ago. Basic loss per share from continuing operations was INR 0.04 compared to INR 16.01 a year ago.
R J BIO-TECH LIMITED 
